A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
JL Casanova et al, Cell, June 11, 2020
JL Casanova et al, Cell, June 11, 2020
COVID-19 displays inter-individual clinical variability. The role of human genetics in determining clinical response to the virus remains unclear. Studies of outliers—individuals remaining uninfected despite viral exposure and healthy young patients with severe disease—present a unique opportunity to reveal human genetic determinants of infection and disease.
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
AB Gussow et al, PNAS, June 10, 2020
AB Gussow et al, PNAS, June 10, 2020
Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses.
Longitudinal Surveillance for SARS-CoV-2 RNA Among Asymptomatic Staff in Five Colorado Skilled Nursing Facilities: Epidemiologic, Virologic and Sequence Analysis.
K Quicke et al MEDRXIV, June 9, 2020
K Quicke et al MEDRXIV, June 9, 2020
Sequence analysis of travel-related SARS-CoV-2 cases in the Greater Geelong region, Australia
TR Bhatta et al, MEDRXIV, June 9, 2020
TR Bhatta et al, MEDRXIV, June 9, 2020
Quantifying the prevalence of SARS-CoV-2 long-term shedding among non-hospitalized COVID-19 patients
V Agarwal et al, MEDRXIV, June 9, 2020
V Agarwal et al, MEDRXIV, June 9, 2020
Factors affecting COVID-19 outcomes in cancer patients − A first report from Guys Cancer Centre in London
B Russel et al, MEDRXIV, June 9, 2020
B Russel et al, MEDRXIV, June 9, 2020
.png)
No hay comentarios:
Publicar un comentario